Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I think Tilray will announce good sales but again the operating expenses will be very high. The general opinion is that not much can be expected from this earnings report. And of course this is going to affect Cronos negatively, because both are traded at the same time. Only in the first quarter of 2019 Cronos was able to separate itself from the rest. Everything bad from other companies affects Cronos, but the good rarely has a positive effect on Cronos. I follow Aphria, CGC, Aurora and Tilray. Aphria performed well, and CGC is taking steps to make growth safer and more sustained. But I repeat, if it affected and will do it negatively, the issue is that Cron at this price is already quite beaten, and anything below 5.50 is a BUY. Aurora will take a long time to get out of there, but she is the favorite of Millennials. It is just an opinion about what I read and perceive.
I agree with that.
Excuses ... I read between the lines, and Mike Gorenstein starts with words like "long term" and that is clear evidence that this is going to be very slow, very slow. This year is already close to half and we continue with the promises of a better future ... Business in the USA. USA They are little reflected in the report. See more Israel ... At this rate, we ended the year with $ 40 million profit, hopefully. Nothing like the $ 100 million we all expected. On the other hand, Altria seems to be in a process of change, and on that side I don't see much help. Juul, which was bought almost at par, is now worth 3 times less than when it was bought ... It seems that Altria didn't know what she was buying, and I'm afraid the same could happen with Cronos.
Cronos "The Bagholder Maker" LOL
What? Where did you see that? I only see 8.43M
I also don't want to sound pessimistic but I don't expect anything new on Friday. They will give us some news that we will see if it works in 1 or 2 quarters, but this is very slow. However, I consider that the price of the stock is very devalued, at least it should be quoted for what Altria paid in its day. We're not much better, but neither has Cronos backtracked. It is together with Aphria, I think, that the only two in the sector with sustained growth. The rest have had to cut personnel, reduce investments ...
I agree with that.
Well i don't think so... :( the time of the rallys is over
We need good news, or at least news... The $ 10 seems a long way from here ...
Hardly anyone usually writes well about Cronos, so ... Cronos was only loved in the first quarter of 2019. It would be a surprise to see good numbers. What really worries me is that I don't see Cronos doing anything ... for me there is nothing new. And time passes ...
I accompany you in your pain brother ... a year with nothing new and good to say ... it seems that we will not see this resurface until 2025
Cronos Group (CRON CN) downgraded to Market Perform with a C$9.17 (5% upside) price target at Raymond James. Shares (NASDAQ:CRON) up a fraction in the U.S.
https://seekingalpha.com/news/3564582-citi-bullish-on-reference-labs-in-premarket-analyst-action?utm_medium=email&utm_source=seeking_alpha&mail_subject=cron-citi-bullish-on-reference-labs-in-premarket-analyst-action&utm_campaign=rta-stock-news&utm_content=link-3
And I'm not saying the opposite, but it doesn't ... Cronos' valuation is very complex, and it can't be compared to its peers either, however, it moves just like the rest ... you can believe what you want, but reality is different.
The reason it has not been further reduced is because the consensus is that 5.50 is the book value ... it is the reason. Chronos should show sales of 15 million in the next profit or it will go down a lot from here
Ok, Thank you.
I dont understand your comment, can you explain me?
For the long term, Cronos may improve ... but in the short term they are not an attractive stock. I think those of us who are left are a lot of Bagholder who apparently will spend a lot of time trapped here ... I can only say Go Cron ... but FAST
For those of us who have been here for a while, these prices are just a joke ... they just go down and down. At the moment there is nothing good to say, although I would like to hear interesting news, but this year of silence has been disastrous.
Apparently the purchase of Lord Jones has been of no use in all these months. It's amazing how more than a year has passed since Altria's investment and I still don't see any action ... This is a company with enormous potential that seems to be on hold.
https://www.investors.com/news/cronos-group-backs-away-from-u-s-marijuana-stocks-out-on-their-own/?src=A00220&yptr=yahoo
"Traders should watch for a breakout from these levels toward reaction highs of around $9.00 or the 200-day moving average at $9.77. If the stock fails to break out, traders could see a move toward reaction lows of $4.00. Trendline resistance remains robust at around $6.25, but technical indicators point to an increasingly bullish move to test that level."
https://www.investopedia.com/cronos-attempts-breakout-amid-rising-cannabis-demand-4800521
I agree with you. Go CRON.
Well... maybe not... is down 9% ... Big earnings but big losess. The other cannabis companies are the ballast that sinks Cronos.
It is very difficult to cover something of that magnitude. In any case, and well said, Cronos is not a farmer, he is a researcher ... That is why it has always been a mistake to compare Cronos with any other cannabis company. There are many people who invest and do not worry or read a little where you put your money ...
...or not, this is Wall Street. In Cronos everything is possible. This is a telegram to the shorts...
That is the news that I am waiting for, it will be the difference between being a farm or a company of the 21st century. The reason for my investment in Cronos is that I have seen it as a company that focuses on R&D and not on its ability to produce large quantities. That is why it has always been undervalued, it is difficult to see the size of the iceberg from the surface, and it is very difficult to compare it with the rest of the companies in the sector. That is why I have always found these prices ridiculous for a company with so much potential.
Amen
It would be fun to see that. Hahaha.
Deja vu! Last year was the same scenario. The difference I see this time is that we have Altria and the numbers have come out better than CGC and TLRY. On the other hand, we have cash ... Go CRON.
Exactly.
Great!
6 months ago BOfA had a goal of $ 25
"Company Market Cap Net Cash MC/Net Cash Canopy Growth (NYSE:) $6.7 billion $1.8 billion 3.7x
Aphria (NYSE:) $1.2 billion $61 million 19.7x
Aurora Cannabis (NYSE:) $3.6 billion -$243.2 million -14.8x
Tilray $2.2 billion -13.8x
Cronos $2.8 billion $1.7 billion 1.6x
Hexo (NYSE:) $626.1 million $80.7 million 7.8x"
"No. CRON stock is not severely overvalued"
https://www.nasdaq.com/articles/investors-should-use-other-metrics-to-evaluate-cronos-group-stock-2019-11-08